Avoid The FOMO Trap: Why Chasing SGX Tech Rallies Ignores Weak Balance Sheets | 🦖EP1594

Avoid The FOMO Trap: Why Chasing SGX Tech Rallies Ignores Weak Balance Sheets | 🦖EP1594

The market sees SGX tech up 79%, but the forensic ledger sees sub 1% yields and balance sheets priced for perfection. When I stack AEM, Nanofilm and UMS against Venture, the gap is brutal: one counter pays you storm-grade cash flow, the others pay you almost nothing for taking full equity risk. My stance is simple as a retirement investor in my 40s: momentum cannot substitute for solvency and yield that actually clears Iggy's Forensic Compliance Standards.

If the six month T-bill is already paying around 1.4% with zero equity risk, then accepting 0.2% to 0.5% from high-multiple tech names fails every version of a rational risk premium for CPF and SRS capital. My forensic floor remains 3.2% and the yield hurdle stays at 4.7%, because anything less means you are donating returns to the market instead of building a retirement paycheck. In a stretched SGX tape, the only real question is whether your portfolio is being paid properly for the risk it is carrying.